3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
20
Prostatic Neoplasms
11
Neoplasm Metastasis
9
Melanoma
8
Lung Neoplasms
8
Carcinoma, Renal Cell
8
Carcinoma, Non-Small-Cell Lung
8
Carcinoma, Hepatocellular
8
Kidney Neoplasms
7
Sarcoma
6
Liver Neoplasms
6
Triple Negative Breast Neoplasms
3
Thyroid Neoplasms
3
Small Cell Lung Carcinoma
3
Osteosarcoma
3
Desmoid Tumors
3
Carcinoma, Ductal, Breast
3
Uterine Cervical Neoplasms
2
Urinary Bladder Neoplasms
2
Tongue Neoplasms
2
Pain
2
Keratosis, Actinic
2
Esophageal Neoplasms
2
Disease
2
Cholangiocarcinoma
2
Carcinoma, Transitional Cell
2
Carcinoma, Intraductal, Noninfiltrating
2
Breast Neoplasms, Male
2
Wilms Tumor
1
Uveal Melanoma
1
Interventions
lenvatinib
3
Surgical Procedures, Operative
3
Fluorouracil
3
Drug Therapy
3
Oxaliplatin
2
Leucovorin
2
Gemcitabine
2
Folfox protocol
2
regorafenib
1
gemcitabine-oxaliplatin regimen
1
durvalumab
1
donafenib
1
apatinib
1
Radiotherapy
1
Hepatectomy
1
Floxuridine
1
Cryosurgery
1
Cisplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Cirrhosis, Familial, with Pulmonary Hypertension
×
Cryosurgery
×
Clear all
NCT07070700
2025-08-12
CASTLE-ZS-02
Fudan University
Phase 2
Recruiting
56 enrolled